A novel single cDNA amplicon pyrosequencing method for high-throughput, cost-effective sequence-based HLA class I genotyping

Human Immunology

Volumn 71, Issue 10, 2010, Pages 1011-1017

  Lank, Simon M ^a   Wiseman, Roger W ^a   Dudley, Dawn M ^b   O'Connor, David H ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

High throughput; Human leukocyte antigen; Multiplexing; Pyrosequencing; Sequence based typing

Indexed keywords

COMPLEMENTARY DNA; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN;

AMPLICON; ARTICLE; COMPUTER MODEL; DATA ANALYSIS; GENOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; COST-BENEFIT ANALYSIS; DNA PRIMERS; DNA, COMPLEMENTARY; GENES, MHC CLASS I; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTOCOMPATIBILITY TESTING; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SEQUENCE ANALYSIS, DNA;

EID: 77956618377     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.07.012     Document Type: Article

References (37)

1. Lewinsohn D.A., Winata E., Swarbrick G.M., Tanner K.E., Cook M.S., Null M.D., et al. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog 2007, 3:1240-1249.
2. Sanchez A., Wagoner K.E., Rollin P.E. Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: Identification of alleles associated with fatal and nonfatal disease outcomes. J Infect Dis 2007, 196(suppl 2):S329-S336.
3. Hill A.V., Allsopp C.E., Kwiatkowski D., Anstey N.M., Twumasi P., Rowe P.A., et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 1991, 352:595-600.
4. Alexander L., Cuchura L., Simpson B.J., Andiman W.A. Virologic and host characteristics of human immunodeficiency virus type 1-infected pediatric long term survivors. Pediatr Infect Dis J 2006, 25:135-141.
5. Guerini F.R., Tinelli C., Calabrese E., Agliardi C., Zanzottera M., De Silvestri A., et al. HLA-A*01 is associated with late onset of Alzheimer's disease in Italian patients. Int J Immunopathol Pharmacol 2009, 22:991-999.
6. Mallal S., Phillips E., Carosi G., Molina J.M., Workman C., Tomazic J., et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008, 358:568-579.
7. Gao X., Nelson G.W., Karacki P., Martin M.P., Phair J., Kaslow R., et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001, 344:1668-1675.
8. Thorsby E. Lie BA HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. Transpl Immunol 2005, 14:175-182.
9. Baxter-Lowe L.A., Maiers M., Spellman S.R., Haagenson M.D., Wang T., Fernandez-Vina M., et al. HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. Biol Blood Marrow Transplant 2009, 15:971-981.
10. Morishima Y., Sasazuki T., Inoko H., Juji T., Akaza T., Yamamoto K., et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002, 99:4200-4206.
11. Shankarkumar U., Pawar A., Ghosh K. Implications of HLA sequence-based typing in transplantation. J Postgrad Med 2008, 54:41-44.
12. Zachary A.A., Kopchaliiska D., Jackson A.M., Leffell M.S. Immunogenetics and immunology in transplantation. Immunol Res 2010, 47:232-239.
13. Hedrick P.W. Pathogen resistance and genetic variation at MHC loci. Evolution 2002, 56:1902-1908.
14. Hughes A.L., Yeager M. Natural selection at major histocompatibility complex loci of vertebrates. Annu Rev Genet 1998, 32:415-435.
15. Prugnolle F., Manica A., Charpentier M., Guegan J.F., Guernier V., Balloux F. Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 2005, 15:1022-1027.
16. Marsh S.G. Nomenclature for factors of the HLA System, update February 2010 2010, Tissue Antigens, (Epub ahead of print).
17. Robinson J., Waller M.J., Fail S.C., McWilliam H., Lopez R., Parham P., Marsh S.G. The IMGT/HLA database. Nucleic Acids Res 2009, 37:D1013-D1017.
18. Robinson J., Waller M.J., Parham P., de Groot N., Bontrop R., Kennedy L.J., et al. IMGT/HLA and IMGT/MHC: Sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 2003, 31:311-314.
19. Bunce M., Young N.T., Welsh K.I., Molecular H.L.A. Typing-the brave new world. Transplantation 1997, 64:1505-1513.
20. Chen M.J., Chu C.C., Shyr M.H., Lin C.L., Lin P.Y., Yang K.L. Detection of a rare caucasoid HLA-DRB1*0337 in a Taiwanese bone marrow donor using sequence-based typing method. Int J Immunogenet 2010, 37:1-3.
21. Yang K.L., Chu C.C., Huang C.H., Lin S.Z., Hsu W.L., Liu D.W., Lin P.Y. Discovery of HLA-DRB1*0331 in a Taiwanese marrow donor and the importance of sequence-based typing in a rare or previously unrecognized allele. Int J Immunogenet 2007, 34:91-95.
22. Listgarten J., Brumme Z., Kadie C., Xiaojiang G., Walker B., Carrington M., et al. Statistical resolution of ambiguous HLA typing data. PLoS Comput Biol 2008, 4:e1000016.
23. Wu G.G., Cheng L.H., Li Z., Deng Z.H., Zou H.Y., Wei T.L., et al. Identification of a new HLA allele, A*1114, in a Chinese family. Tissue Antigens 2003, 61:253-255.
24. Adams S.D., Barracchini K.C., Simonis T.B., Stroncek D., Marincola F.M. High throughput HLA sequence-based typing (SBT) utilizing the ABI Prism 3700 DNA Analyzer. Tumori 2001, 87:S40-S43.
25. Abbott W.G., Tukuitonga C.F., Ofanoa M., Munn S.R., Gane E.J. Low-cost, simultaneous, single-sequence genotyping of the HLA-A, HLA-B and HLA-C loci. Tissue Antigens 2006, 68:28-37.
26. Paul P., Thomas D., Kawczak P., Good D., Cook D.J., Ball E.J. Resolution of cis-trans ambiguities between HLA-DRB1 alleles using single-strand conformation polymorphisms and sequencing. Tissue Antigens 2001, 57:300-307.
27. Adams S.D., Barracchini K.C., Chen D., Robbins F., Wang L., Larsen P., et al. Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: When precise nucleotide sequencing leads to imprecise allele identification. J Transl Med 2004, 2:30.
28. Gabriel C., Danzer M., Hackl C., Kopal G., Hufnagl P., Hofer K., et al. Rapid high-throughput HLA typing by massively parallel Pyrosequencing for high-Resolution allele identification. Hum Immunol 2009, 70:960-964.
29. Bentley G., Higuchi R., Hoglund B., Goodridge D., Sayer D., Trachtenberg E.A., Erlich H.A. High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens 2009, 74:393-403.
30. Rothberg J.M., Leamon J.H. The development and impact of 454 sequencing. Nat Biotechnol 2008, 26:1117-1124.
31. Wiseman R.W., Karl J.A., Bimber B.N., O'Leary C.E., Lank S.M., Tuscher J.J., et al. Major histocompatibility complex genotyping with massively parallel pyrosequencing. Nat Med 2009, 15:1322-1326.
32. Edgar R.C. MUSCLE ERC: A multiple sequence alignment method with reduced time and space complexity. BMC Bioinform 2004, 5:113.
33. Kent W.J. BLAT-the BLAST-like alignment tool. Genome Res 2002, 12:656-664.
34. Meyer M., Stenzel U., Hofreiter M. Parallel tagged sequencing on the 454 platform. Nat Protoc 2008, 3:267-278.
35. Hamady M., Walker J.J., Harris J.K., Gold N.J., Knight R. Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods 2008, 5:235-237.
36. Lu Y., Boehm J., Nichol L., Trucco M., Ringquist S. Multiplex HLA-typing by pyrosequencing. Methods Mol Biol 2009, 496:89-114.
37. Hentze M.W., Kulozik A.E. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 1999, 96:307-310.